publicações selecionadas HFE hemochromatosis: an overview about therapeutic recommendations Burden of Sickle Cell Disease: A Brazilian Societal Perspective Analysis VASO-OCCLUSIVE CRISIS IN A 12-MONTH PERIOD: PREVALENCE AMONG BRAZILIAN PATIENTS WITH DIAGNOSIS OF SICKLE CELL DISEASE COMPLICATIONS AND HYDROXYUREA USE AMONG BRAZILIAN PATIENTS WITH SICKLE CELL DISEASE: A COMPARISON WITH OTHER COUNTRIES Estimated mortality rates of individuals with sickle cell disease in Brazil: real-world evidence Maternal and perinatal outcomes in pregnant women with sickle cell disease: an update Real-World Data on the Occurrence of Vaso-Occlusive Crises (VOCs) in Patients with Sickle Cell Disease (SCD) and a High Baseline Disease Burden Treated with Crizanlizumab: Results from a Managed Access Program (MAP) Economic burden of sickle cell disease in Brazil Novel Insights into the Pathophysiology and Treatment of Sickle Cell Disease Iron deficiency anemia in women: pathophysiological, diagnosis, and practical management How I treat anemia in the perisurgical setting - Revisitando o Manejo da Anemia no Paciente Cirúrgico- Comentário do Especialista Quality of Life Scores Remained Different among the Genotypic Groups of Patients with Suspected Hemochromatosis, Even after Treatment Period S121: REDUCED RATE OF VASO-OCCLUSIVE CRISES (VOCS) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD) TREATED WITH CRIZANLIZUMAB FOR 12 MONTHS: RESULTS FROM A REAL-WORLD, MANAGED ACCESS PROGRAM (MAP) Avaliação laboratorial da deficiência de ferro em doadores de sangue Novel mutations in the bone morphogenetic protein 6 gene in patients with iron overload and non-homozygous genotype for the HFE p.Cys282Tyr mutation Hemocromatose Hereditária contribuição para o estudo da prevalência, das características clínicas e laboratoriais, da análise dos antígenos HLA-A e das mutações C 282Y, H63D e S65C do gene HFE em população Brasileira com evidência laboratorial de sobrecarga de ferro Brazilian family with hyperferritinemia-cataract syndrome: case report SATISFACTION AND ADHERENCE TO SICKLE CELL DISEASE TREATMENT IN BRAZIL: CROSS-SECTIONAL ANALYSIS CONSIDERING PATIENTS AND HEALTHCARE PROVIDER PERSPECTIVES Consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria Sickle Cell Disease Mortality in Brazil: Real-World Evidence Contribuição para o estudo da Hemocromatose Hereditária no Brasil
